The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, February 02, 2022
Navitor Pharmaceuticals announced that Janssen Pharmaceuticals has acquired Anakuria Therapeutics, Inc., a company recently formed by Navitor to ...
read more
Thursday, February 03, 2022
The FDA has issued a draft guidance for industry titled “Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs.” ...
read more
Tuesday, February 08, 2022
New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine for COVID-19 are just...
read more
Tuesday, February 08, 2022
Hoffmann-La Roche Limited (Roche Canada) announced that on January 14, 2022, Health Canada has authorized TECENTRIQ® (atezolizumab) as monotherapy for...
read more
Wednesday, February 09, 2022
Sunovion Pharmaceuticals Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. announced that the first patient has been randomized in ...
read more
Wednesday, February 09, 2022
Thermo Fisher Scientific has announced a multiyear partnership with Medidata Acorn AI, a Dassault Systèmes company. Through this partnership, the PPD ...
read more
Monday, February 14, 2022
The U.S. Food and Drug Administration took new steps aimed at fostering the development of non-addictive alternatives to opioids to manage acute pain ...
read more
Friday, February 11, 2022
Evofem Biosciences, Inc., announced that the U.S. Food and Drug Administration (FDA) has awarded "Qualified Infectious Disease Product" (QIDP) ...
read more
Monday, February 14, 2022
Eli Lilly and Company announced an agreement with the U.S. government to supply up to 600,000 doses of investigational drug bebtelovimab for at least ...
read more
Monday, February 14, 2022
The U.S. Food and Drug Administration has been notified by Pfizer that new data have recently emerged regarding its emergency use authorization ...
read more
Monday, February 14, 2022
ProBioGen has announced a multi-product commercial license agreement with AstraZeneca to use the GlymaxX technology. Following evaluation of the ...
read more
Monday, February 14, 2022
CytoReason has established itself as a global leader in computational modeling of human diseases. The company's multidisciplinary team of 65 leading ...
read more
Thursday, February 17, 2022
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for...
read more
Thursday, February 17, 2022
AstraZeneca’s Marketing Authorization Application (MAA) for nirsevimab has been accepted under an accelerated assessment procedure by the European ...
read more
Friday, February 18, 2022
Sandoz announced the launch of generic oncology medicine lenalidomide, indicated for several haemato-oncology conditions as recommended by the latest ...
read more